Discordance in Genotypic and Phenotypic anti-tuberculosis drug susceptibility results: time to reconsider critical concentration.

Arti Shrivas,Sarman Singh,Jitendra Singh,Prem Shankar,Payal Soni,Syed Beenish Rufai,Anand Maurya,Shashank Purwar
DOI: https://doi.org/10.1101/2024.07.08.602571
2024-07-08
Abstract:Objective: To correlate rpoB mutations found on the sanger sequencing in Mycobacterium tuberculosis (MTB) isolates with Minimum Inhibitory Concentrations (MICs) to the rifampicin. Methods-We assessed the minimum inhibitory concentrations (MICs) for 151 archived clinical MTB isolates that were determined phenotypically susceptible to RIF (101;66.89%) and remaining fifty (50;33.11%) were resistant to RIF by BACTEC MGIT SIRE DST. MIC values were determined using Colorimetric redox indicator (Resazurin/REMA) method and results were correlated with rpoB gene mutations associate with rifampicin resistance found. Results: Comparing the MIC and critical concentration, we found that 15 of these 101 (14.85%) isolates were misclassified by MGIT-960 as sensitive at standard critical concentration (1.0µg/mL) though these were found to have low-level RIF resistance by CRI assay (MIC 0.50µg/mL to 1.0µg/mL) and sanger sequencing. We found that all of 15 isolates contained non-synonymous mutations, the commonest being the Ile572Phe (7, 46.66%), followed by Leu533Pro (3, 20.0%), His526Leu (2, 13.33%), His526Asn+Ile572Phe (1), Asp516Tyr (1), and Leu533Pro+Pro564Arg (1). These mutations are reported to confer low-level RIF resistance. But we did not find any mutation at MIC <0.25μg/mL. Conclusion: We found that a significant number of MTB isolates have phenotypic and genotypic discordance. Taking 1.0µg/mL of rifampicin as a critical concentration, isolates from approximately 15% patients are misidentified as susceptible to rifampicin, even when these strains carry low-level drug resistance conferring mutations and have the potential to develop clinical MDR-TB.
Microbiology
What problem does this paper attempt to address?